In-Vitro Toxicology Testing Market Size, Share Global Analysis Report, , 2021 – 2026

Industry Insights

[183+ Pages Report] We recently published a new market report named global In-vitro Toxicology Testing Market which incorporates the most recent offers. With a CAGR of 10.7%, we anticipate a market value of USD 9.7 Billion in 2020, rising to USD 16.1 Billion in 2026.

Market Overview

In-vitro toxicology refers to the scientific breakdown of the compounding effect that toxic chemical substances has on a batch of cultured bacterial arrays or any set of mammalian cells. In-vitro refers to methods and procedures that are potentially used for identification of hazardous chemicals and/or to confirm the lack of certain toxic traits in the initial stages of developing new substances for a range of therapeutic, agricultural, and food additives compounds. Various global organizations across the globe often incorporate in-vitro toxicology testing methods in order to better prepare risk assessment reports on the human anatomy.

Industry Growth Factors

The primary driving factors for the growth of the in-vitro toxicology testing market are the intense evolution of 3D cell culture systems that render the host physiology that ensures potentially limitless testing of the human compound without any real-life animal testing. Factors pertaining to a risen acceptance of in-vitro toxicology and improvement in statistical computing models and simulations will further drive the growth of the market. Additional factors that can significantly boost the growth of the in-vitro toxicology testing market can be contributed toward a driven interest in developing better high-throughput screening (HTS) which further enables manufacturers to produce a cheaper and cost-effective testing alternative.

Moreover, factors such as a rise in checking drug testing and manufacturing measures, a rise in the safety of consumables, increased screening during production, and a generalized trend of increase of in-vitro testing have been observed. These factors will contribute heavily in opening new revenue opportunities for in-vitro toxicology testing market globally. Advancements in the technology have led to features such as early detection of drug safety standards which will further boost the growth of the market during the forecast. The rise in targeted focus such as drug discovery solutions and a rising trend of personalized medicine will push the market toward a ballooned state. Rising ethical concerns regarding animal testing procedures and efforts undertaken by global organizations can hamper the growth of the market to a certain extent.

Report Scope

Segmentation Analysis

The global in-vitro toxicology testing market can be segmented on the basis of product, technology, method, application, end-users, and regions.

On the basis of the product, the global in-vitro toxicology testing market can be divided into consumables, assays, equipment, software, and services. The assays can be further broken down into bacterial toxicity assay, enzyme toxicity assay, cell-based elisa & western blots, receptor-binding assays, and other assays. Consumables will account for the largest market share during the advent of the forecast owing to increasing demand for a higher quality of reagents and repeated usability. On the basis of technology, the global in-vitro toxicology testing market can be bifurcated into cell culture technology, high throughput technology, molecular imaging & OMICS technology. Cell culture technology is expected to dominate the market during the segment owing to consistency and reproducibility coupled with early detection of toxicity in any drug-based trial. On the basis of method, the global in-vitro toxicology testing market can be broken down into cellular assay, biochemical assay, in silico, and ex-vivo. Cellular assays are expected to dominate the market during the forecast due to contributing factors ranging from easy availability and dependability of these kits.

On the basis of application, the global in-vitro toxicology testing market can be segmented into systemic toxicology, dermal toxicology, endocrine disruption, ocular toxicity, and others. The segment of systemic toxicology is expected to witness the largest market share during the forecast owing to the development of multiple organ plates with simulated blood flow for assessment of systemic toxic drives coupled with rising adoption for replacing animal testing with in-vitro testing. On the basis of end-users, the global in-vitro toxicology testing market can be fragmented into pharmaceutical, cosmetics, and household products, diagnostics, chemicals industry, & food industry. The pharmaceutical sector is expected to contribute to the largest share in the segment owing to the increasing usage of toxicology testing in pharmacokinetic analysis for novel and generic modified pharmaceutical product testing.

Regional Analysis

Asia-Pacific is expected to occupy the largest market share during the advent of the forecast. Several contributing factors such as an increase in governmental and local organizations protesting against the use of animals during drug trial development as well as ongoing launches of biologics and biosimilar products by biopharmaceutical industries in the region will drive the growth of the market. Additional, increased government funding for drug discovery studies from the government and private sector alike will boost the sales of the in-vitro toxicology treatment market during the forecast. A low testing and cost-effective method in the region and the presence of key players further pushes the state of in-vitro toxicology testing market toward a ballooned state.

Competitive Players

The key participants in the global in-vitro toxicology testing market are :

• Merck KGaA.
• Charles River
• Bio-Rad Laboratories Inc.
• Abbott.
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Quest Diagnostic Incorporated
• Eurofins Scientific
• Laboratory Corporation of America Holdings
• Evotec
• Creative Bioarray
• Gentonix
• Agilent Technologies

By Product Segment Analysis

• Consumables
• Assays
  • Bacterial Toxicity Assay
  • Enzyme Toxicity Assay
  • Cell-Based Elisa & Western Blots
  • Receptor-Binding Assays
  • Other Assays
• Equipment
• Software
• Services

By Technology Segment Analysis

• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging
• OMICS Technology

By Method Segment Analysis

• Cellular Assay
• Biochemical Assay
• In silico
• Ex-vivo

By Application Segment Analysis

• Systemic Toxicology
• Dermal Toxicology
• Endocrine Disruption
• Ocular Toxicity
• Others

By End-Users Segment Analysis

• Pharmaceutical
• Cosmetics and Household Products
• Diagnostics,
• Chemicals Industry
• Food industry

By Regional Segment Analysis

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of MEA